Xcout Intel
ADmit Therapeutics
ADmit Therapeutics S.L. is a biotechnology company founded in 2017 in Barcelona, Spain, that emerged from the Bellvitge Biomedical Research Institute. The company specializes in developing early diagnostic tools and tests for neurodegenerative diseases.
Subscribe to see ADmit Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ADmit Therapeutics at a glance
ADmit Therapeutics is a biotechnology company headquartered in Spain. It has raised at least $5.9M across the 2 funding rounds on record. Its most recent funding round, Grant, raised $497,652 in May 2026. Xcout tracks 15 named people at ADmit Therapeutics, including Marta Barrachina (CEO Co-Founder Board Member).
ADmit Therapeutics leadership
- Marta BarrachinaCEO Co-Founder Board Member
- Ferran PratChairman of the Board
- Marta BarrachinaCEO Co-Founder Board Member
- Jordi GascónCo-Founder and Member of the Medical Advisory Board
- Ramón ReñéCo-Founder and Member of the Medical Advisory Board
- Alfred Fu Kong LuiLaboratory Director
9 more named people on record for ADmit Therapeutics, with roles, board committees and tenure — see the full roster →
ADmit Therapeutics funding rounds
At least $5.9M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Grant | $497,652 | 7 named | |
| — | $5.4M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
ADmit Therapeutics competitors
A few of ADmit Therapeutics's closest competitors — see the full list of competitors and alternatives →
Reveal Genomics, S.L. is a biotechnology company founded in 2020 and headquartered in Barcelona, Spain. The company develops innovative genomic tools to improve breast cancer treatment and personalized medicine.
Veravas Inc. develops diagnostic technology and testing solutions, including its proprietary VeraBIND platform, designed to reduce laboratory test interference and detect hard-to-find biomarkers. The company primarily serves clinicians, researchers, and patients by providing tools and assays focused on the early detection of complex conditions such as Alzheimer's disease and other dementias.
Saccade is a medical and diagnostic laboratory startup located in San Francisco, California. The company is developing early screening technology and diagnostic tests for Alzheimer's disease.
Cognision is a biotechnology research company headquartered in Louisville, Kentucky (with primary offices also noted in Boston, Massachusetts). The firm develops advanced neurological assessment tools and diagnostic technologies.
Athena Diagnostics provides specialized diagnostic and genetic testing services focusing on neurological diseases, neuromuscular disorders, and developmental disorders such as Alzheimer's disease and muscular dystrophy. The company serves patients and healthcare providers by offering test catalogs, sample collection kits, requisition resources, and billing support.
Get ADmit Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ADmit Therapeutics in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access